Although it exhibits no homology to synaptojanin 1 in this region, synaptojanin 2 also contains an open reading frame in the 3 region that is subject to alternative splicing. Similar to synaptojanin 1, alternative splicing of synaptojanin 2 is tissue-specific and creates a shorter isoform expressed in brain and a longer form in peripheral tissues. The similar alternative splicing of two homologous proteins in a region of non-homology raises the possibility of evolutionary convergence and supports the significance of the variants. Analysis of mRNAs from three brain regions at different developmental stages revealed that alternative splicing of synaptojanin 2 is a developmentally late event, occurring only after the first postnatal week after the generation of neurons and initial synaptogenesis.
phates at the 3, 4, and 5 positions of the inositol ring in various combinations. The synthesis and hydrolysis of PIPs are mediated by a tightly regulated network of PIP kinases and phosphatases with distinct substrate specificities (1, 2) . Studies in permeabilized PC12 cells demonstrated that a PIP 5-kinase is essential for Ca 2ϩ -triggered exocytosis (3), suggesting that generation of PIPs with 5-phosphates is involved in Ca 2ϩ -regulated exocytosis. PIPs have also been proposed to function in endocytosis because they bind to a number of proteins involved in endocytosis (4 -6) . Because PIPs have such a central role in membrane traffic and signal transduction, termination of the PIP signal by phosphate hydrolysis must be a key regulatory step. A PIP 5-phosphatase called synaptojanin was recently discovered that is enriched in synaptic nerve terminals (7, 8) and may serve to inactivate the PIP 5-phosphate signal.
Synaptojanin is ubiquitously expressed and hydrolyzes soluble inositol 5-phosphates as well as lipidic PIP 2 and PIP 3 phosphorylated in the 5-position (8, 9) . Synaptojanin is composed of three principal domains: an N-terminal domain homologous to the yeast membrane trafficking protein SAC1, a central domain that carries the phosphatase activity, and a C-terminal domain that is not similar to any currently known protein but highly enriched in proline. Three homologues of synaptojanin have been identified in the yeast genome that also contain an N-terminal SAC1 domain and a middle 5-phosphatase domain but differ from synaptojanin and from each other in their C-terminal sequences (1) . Synaptojanin was first identified as a phosphoprotein purified on immobilized Grb2 (7) . Later the C-terminal proline-rich domain of synaptojanin was shown to interact with the SH3 domain of amphiphysin, suggesting a function in endocytosis (10) . However, the relative significance of the enzymatic activity and protein interactions of synaptojanin have not been elucidated.
In addition to the three principal domains, the synaptojanin mRNA contains an open reading frame in the 3Ј region separated from the proline-rich C-terminal sequence by a stop codon (8) . Although synaptojanin was initially thought to be brain-specific, PCR experiments revealed that it is ubiquitously expressed and that it is alternatively spliced (11) . In brain, synaptojanin is present in a splice variant containing a stop codon after the proline-rich domain, whereas in peripheral tissues the stop codon is spliced out, and a longer protein is produced in which the open reading frame is fused to the proline-rich sequence. Thus two different forms of synaptojanin are produced, a shorter form that is expressed primarily in neurons in brain where it seems to be concentrated in nerve terminals and a longer ubiquitous form (11) .
We have now identified a second isoform of synaptojanin that is similar in its N-terminal SAC1 and phosphatase domains but differs in the C-terminal domain. Interestingly, this isoform is also subject to alternative splicing at the C terminus despite the lack of homology between synaptojanins in the alterna-* This work was supported by National Institutes of Health Grant RO1-MH52804 and by funds from the Perot Family Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. 
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tively spliced sequences. Our data suggest that in brain and other mammalian tissues, PIP signaling may be more complex than previously envisioned and involve multiple differentially regulated PIP 5-phosphatases that are subject to coordinate alternative splicing.
EXPERIMENTAL PROCEDURES
Cloning, Sequencing, and Construction of Expression Vectors-GenBank™ was searched using the BLAST programs of the NCBI. A single candidate synaptojanin homologue was identified, the corresponding clone was obtained from the IMAGE Consortium (clone 360567; Ref. 12) , mapped with restriction endonucleases, and sequenced after subcloning into pBlueScript II using standard procedures. The 5Ј AvaI fragment of the clone was used as a probe to screen a mouse brain cDNA library (Stratagene). Pooled ZAP clones were plaque-purified and sequenced after in vivo excision using standard procedures (13, 14) . Sequence analysis was performed using the DNASTAR software package (DNASTAR Inc.). The sequences have been submitted to GenBank™ (accession number AF026123). A synaptojanin 1 expression vector (pMESJ1) was constructed by amplifying its complete coding region by PCR using oligonucleotides 1581 and 1578 (sequences GC-GAATTCGGCTGCCTCTGAAGAAAGGAGAATGGCG and GCGAC-TAGTTACCCTGTTGGTTGCTCCTGTTGTAGC) and cloning the PCR product into the EcoRI and SpeI sites of pME18Sf. A synaptojanin 2 expression vector (pCMVmycSJ2) containing the putative phosphatase domain and the C-terminal domain (residues 505-1206; see Fig. 1 ) N-terminally fused to the myc epitope was created by subcloning the BamHI-AvrII fragment of the cDNA into the BglII and XbaI sites of pCMV5.
RNA Purification and cDNA Synthesis-Total RNA was purified from 100 mg each of adult mouse brain, postnatal mouse brains (days 1-20), embryonic mouse brain (day 18), adult mouse heart, lung, spleen, liver, kidney, testis, and skeletal muscle tissues using RNASTAT-60 (TEL-TEST Inc). RNA concentration was determined by absorbance at 260 nm. 10 g of each RNA sample were reverse transcribed using SuperScript System (Life Technologies, Inc.) with oligo(dT) [12] [13] [14] [15] [16] [17] [18] primer according to the manufacturer's instructions.
PCR Analysis-Forward and reverse primers GCGGATCCTTACA-ACGTCAAACAGATCAAAACCAC and GCGAATTCCACTCGGCCTC-CTCTCAACACCTCTC (BamHI and EcoRI sites are underlined) were used for PCR amplifications with AmpliTAQ DNA polymerase (PerkinElmer). PCRs were performed in 38 cycles, with the first three cycles at 94°C for 1 min, 65°C for 1 min, and 72°C for 2 min followed by 35 cycles at 94°C for 45 s and 72°C for 1 min. Products were separated on 2% agarose gels in TAE buffer (40 mM Tris-acetate, pH 8.3, 1 mM EDTA), purified using a Qiaex kit (Qiagen), and cloned into pBlueScript vector after digestion with BamHI and EcoRI for sequencing. The sequences of the PCR products consistently contained multiple substitutions compared with the sequences of the cDNA clones, possibly because they were derived from different mouse strains (see GenBank™ entry). mM dithiothreitol, 1 mM phenylmethylsulfonyl fluoride, 10 mg/l benzamidine, 10 mg/l leupeptin, and 1 M pepstatin A. The lysate was incubated on ice for 30 min and cleared by high speed centrifugation (100,000 ϫ g for 1 h). Proteins from the transfected COS cells were immunoprecipitated using a polyclonal rabbit serum raised against bacterially expressed synaptojanin 1 (T694) for synaptojanin 1-transfected COS cells and monoclonal antibody 9E10 against the myc epitope for synaptojanin 2-transfected COS cells because synaptojanin 2 was expressed as a myc epitope fusion protein. All immunoprecipitations were also carried out with control transfected COS cells. Immunoprecipitates immobilized on protein A-Sepharose beads were washed five times at 4°C in assay buffer (4 mM CHAPS, 0.1 M NaCl, 50 mM HEPES-NaOH, pH 7.4, 0.5 mM EGTA, 5 mM MgCl 2 ). The PIP 2 activity of the washed immunoprecipitates was then determined essentially as described (15) . For this purpose, a lipid mix containing 0.67 g/liter phosphatidylcholine, 0.33 g/liter phosphatidylserine (from Avanti lipids), and 1.4 M 3 H-phosphatidylinositol-(4,5)-bisphosphate (2.4 Ci/ mmol; NEN Life Science Products) was dispersed in assay buffer by sonication. Equal volumes (30 l) of the lipid mix and the bead suspension were combined and incubated for 30 min at 37°C. Thereafter 50 g of total phosphoinositides (Sigma) were added as carrier lipids, and samples were extracted with 225 l of chloroform:methanol:concentrated HCl (100:200:1) followed by extraction with 75 l of chloroform and 0.1 N HCl. The chloroform was evaporated under nitrogen, and lipids were redissolved in chloroform and separated by thin layer chromatography on Whatman silica gel 6 nm plates using a n-propanol, NH 4 OH, and water (65:20:15) as solvent system. The corresponding spots for phosphatidylinositol, PIP, and PIP 2 were identified using lipid markers as internal standards visualized with iodine vapors, scraped out, and counted by liquid scintillation counting.
Measurements of PIP Phosphatase Activities by Synaptojanins-COS

RESULTS
Identification of Synaptojanin 2-The yeast genome contains three genes for synaptojanin-like proteins, but only a single such gene was described in mammals (1) . Synaptojanin may be considered as corresponding to two isoforms because it is alternatively spliced in a tissue-specific manner (11) . Yet it seemed unlikely that the mammalian genome would not contain additional 5-phosphatases of this family in view of the apparent complexity of synaptojanin-like PIP 5-phosphatases in yeast. Therefore we searched the EST data bank for synaptojanin homologues. We identified a single mouse EST closely related to synaptojanin (clone 370576) and named the corresponding protein synaptojanin 2. Northern blots of synaptojanin 2 showed that it is ubiquitously expressed, with the highest levels in heart and brain (data not shown).
Sequencing of the mouse EST clone suggested that it is nearly full-length. Screening a mouse cDNA library allowed us to isolate more 5Ј sequences and to assemble a composite sequence that contains almost the complete coding sequence of synaptojanin 2 (Fig. 1) . Based on the comparison with synaptojanin 1, approximately 30 amino acids are missing. Mouse synaptojanin 2 is closely related to synaptojanin 1. Both synaptojanins contain an N-terminal SAC1 domain and a central PIP 5-phosphatase region (Fig. 2) . The N-terminal SAC1 domains of synaptojanins 1 and 2 are 53.7% identical, and their central PIP 5-phosphatase domains are 57.6% identical (Fig. 1) . In contrast, the C-terminal domains are not conserved between the synaptojanins (19.3% identity). The C-terminal domain of synaptojanin 2 exhibits no similarity to proteins currently in the data banks. This domain is not highly enriched in prolines (8.7% prolines), whereas the sequence of the corresponding Cterminal domain of synaptojanin 1 is highly enriched in prolines (19.8% prolines). The domain structure and homology between synaptojanins 1 and 2 suggest that they represent isoforms with shared N-terminal and divergent C-terminal domains.
PIP Phosphatase Activities of Synaptojanins 1 and 2-Recent studies demonstrated that synaptojanin 1 is a PIP phosphatase that hydrolyzes PIP 2 and PIP 3 (9, 10, 15) . The homology of synaptojanin 2 to synaptojanin 1 suggests that synaptojanin 2 may also function as a phosphatase. To directly test this hypothesis, we expressed synaptojanin 1 and 2 by transfection in COS cells. Synaptojanin 1 was expressed as a full-length protein, and synaptojanin 2 was expressed as a truncated protein that was N-terminally fused to the myc epitope to allow efficient immunoprecipitation. COS cells transfected with the synaptojanin vectors, and control plasmids were subjected to immunoprecipitations using antibodies to synaptojanin 1 in case of the synaptojanin 1 transfections (Fig. 3A) or antibodies to the myc epitope in case of the synaptojanin 2 transfections (Fig. 3B) . The PIP phosphatase activity of the immunoprecipitates was measured using 3 H-labeled PIP 2 and thin layer chromatography for detection of the hydrolysis products (15) . The assays unequivocally demonstrated that both synaptojanins hydrolyze PIP 2 to PIP (Fig. 3) . No hydrolysis to phosphatidylinositol was detected as would be expected from the predicted specificity of synaptojanins as 5Ј-phosphatases (1, 15) . The background activity of the control immunoprecipitates was at the level of the assay buffer for synaptojanin 2, suggesting that the entire PIP 2 phosphatase activity measured was due to the transfected protein. In the case of synaptojanin 1, however, the background activity obtained with the immunoprecipitates with the synaptojanin 1 antibodies from the control transfected COS cells was higher than the buffer background, presumably because the synaptojanin 1 antibody reacts with low levels of endogenous synaptojanin 1 present in the COS cells. Together these data show that synaptojanins 1 and 2 have comparable PIP phosphatase activities and that mammals contain multiple related PIP 5-phosphatases.
Alternative Splicing of Synaptojanin 2-The 3Ј-untranslated region of the synaptojanin 2 clone we analyzed contains a long open reading frame (243 residues) that starts 23 bp after the stop codon in a reading frame different from that of the preceding synaptojanin 2 sequence. The sequence of this open reading frame in the 3Ј-untranslated region is enriched in proline (15.0% of residues) but exhibits no other remarkable features. Data base searches failed to detect any similarity of this sequence with current entries. Synaptojanin 1 also contains a large open reading frame in the 3Ј-untranslated region of the brain mRNA that is proline-rich (14.3% of residues). Alternative splicing joins this open reading frame to the 5Ј coding region in peripheral tissues (11) . The presence of a large open reading frame in the 3Ј region of synaptojanin 2 suggests the possibility that this reading frame may also be joined to the synaptojanin 2 coding sequence by alternative splicing in some tissues, similar to the situation with synaptojanin 1. To test this possibility, we performed PCR experiments on first strand cDNA from a variety of tissues (Fig. 4) .
In most tissues, two PCR products were observed: a larger 544-bp product and a shorter 394-bp product (A and B in Fig.  4) . In addition, a third band was occasionally observed that probably is due to an artifact as judged by sequencing (asterisk in Fig. 4) . The two specific PCR products were differentially distributed in different adult tissues; most tissues contain primarily the smaller product and express only low levels of the larger product except for brain, in which the larger product predominates. FIG. 5 . Sequence analysis of the synaptojanin variants generated by alternative splicing. The "A" and "B" products from Fig. 3 were sequenced. Panel A depicts the nucleotide amd amino acid sequences of the region of difference between the A and B products. The boxed sequence in the middle is only present in the A product expressed primarily in brain, resulting in a unique 40-amino acid C terminus terminated by a stop codon. In the B product, this sequence is deleted, resulting in a shorter PCR product that encodes a longer protein whose sequence is shown in panel B. Proline residues are underlined. Note that the alternative splicing of synaptojanin 2 is similar to that of synaptojanin 1 in that it creates a shorter brain isoform and a larger peripheral isoform but that the alternatively spliced sequences share no homology and the alternatively spliced sequence is much larger in synaptojanin 2 (146 bp) than in synaptojanin 1 (27 bp). Sequencing revealed that the larger product corresponds to the sequence of the EST clone ( Fig. 1) and contains a stop codon before the open reading frame in the 3Ј region (Fig. 5) . The sequence of the shorter product was identical to that of the larger product except that it contains an internal deletion of 146 bp that includes the stop codon. This creates a single open reading in which the main coding region of synaptojanin 2 is linked to the 3Ј open reading frame. Thus the longer splice variant encodes a shorter protein whose sequence is shown in Fig. 1 (referred to as synaptojanin 2A) . The shorter splice variant encodes a longer protein (synaptojanin 2B) that lacks the C-terminal 40 residues of synaptojanin 2A but instead contains a unique sequence of 243 residues (Fig. 5) . Whereas the sequences of the PCR products were identical to each other, they exhibited several base pair substitutions with the sequence of the EST clone, possibly because the EST clone was from a different mouse strain than the RNA used for cDNA synthesis for the PCRs.
Developmental Expression of Alternative Splicing of Synaptojanin 2-To characterize the developmental time course of alternative splicing of synaptojanin 2, we also used PCR (Fig.  6 ). Alternative splicing of synaptojanin 2 was not detectable during early development or even in the first postnatal week in mice. In the three brain regions examined, alternative splicing appeared with similar developmental profiles that differed only slightly. It was first observed between postnatal days 9 and 13 in cortex and cerebellum, and a few days later in the olfactory bulb. The appearance of alternative splicing is significantly later than synaptogenesis, which starts in the first week of life, suggesting that alternative splicing may be triggered by synaptogenesis instead of being involved in synaptogenesis.
DISCUSSION
Synaptojanin 1 is a PIP 5-phosphatase that is enriched in nerve terminals and forms a complex with proteins involved in endocytosis (8, 10) . Based on its catalytic activity and protein interactions, synaptojanin 1 may function in terminating a PIP signal for exocytosis or in triggering endocytosis, but its precise function is unclear. In view of the importance of PIP 5-phosphates in signal transduction and membrane traffic (1, 2), PIP 5-phosphatases are likely to be key regulatory enzymes. Although synaptojanin 1 constitutes the major PIP 5-phosphatase in mammalian brain (9) , the presence of multiple related genes in yeast suggests that PIP 5-phosphatase signaling probably is more complex than could be performed by a single enzyme. In the current study, we have identified a second isoform of synaptojanin 1 named synaptojanin 2 that also exhibits PIP phosphatase activity and is also alternatively spliced. These data suggest that in mammals, multiple synaptojanin PIP 5-phosphatases are active.
A unitary domain map emerges for synaptojanins from the analysis of the two mammalian and three yeast proteins (Fig.  1) . All of these proteins consist of an N-terminal SAC1-homology domain, a central catalytic PIP 5-phosphatase domain, and a nondescript C-terminal domain. The SAC1-homology and PIP 5-phosphatase domains are well conserved, whereas the Cterminal regions exhibit no sequence homologies. Thus these proteins represent a family of enzymes with divergent C termini that are evolutionarily conserved from yeast to man. In the three domains of these proteins, only the central domain has a well defined function as a phosphatase, although the biological significance of the phosphatase activity is unclear. The role of the N-terminal SAC1-homology domain is unknown; however, its homology to SAC1, a protein involved in membrane traffic and the cytoskeleton possibly via interaction with inositol derivatives (16, 17) , suggests a similar function. The C-terminal domain in synaptojanin 1 functions as a binding domain for SH3 domains in adaptor proteins such as amphiphysin (10) . Because it is not conserved in synaptojanin 2, this is unlikely to be a central activity of synaptojanin 2.
The most unexpected feature of the synaptojanins may consist in their coordinate C-terminal alternative splicing. Alternative splicing of synaptojanins 1 and 2 is expressed in a tissue-specific manner. Furthermore, it is developmentally regulated in synaptojanin 2. Alternative splicing appears developmentally very late in brain, after synaptogenesis has started. Because protein production lags behind the mRNA synthesis monitored in the PCR experiments, it seems likely that the production of the short form of synaptojanin 2 either accompanies or follows synaptogenesis.
Synaptojanins 1 and 2 are very similar in that both genes produce splicing variants in which the longer variant encoding a shorter protein is primarily expressed in brain and the shorter variant produces a longer protein in peripheral tissues (Fig. 4 and Ref. 11). However, this similar alternative splicing is unexpected because the C-terminal domains of synaptojanins and their alternatively spliced sequences exhibit no homology. Furthermore, the alternatively spliced sequences are of different sizes. The lack of homology in this region and the differences in size suggest that the coordinate alternative splicing of synaptojanins is not the result of evolutionary conservation but of evolutionary convergence, i.e. that it arose independently in evolution in the two different isoforms. If this is correct, there must have been considerable evolutionary pressure in producing the splice variants, even if they are not homologous to each other. Identification of the functions of synaptojanins and of the roles of their C-terminal domains will be instrumental in clarifying this issue.
